Jiaoti Huang MD PhD
Genitourinary Pathology, Obstetrics & Perinatal Pathology, Anatomic Pathology, Surgical Pathology
Professor and Chairman, Department of Pathology, Duke University School of Medicine
Join to View Full Profile
10833 Le Conte AveB186Los Angeles, CA 90095
Phone+1 310-794-1355
Dr. Huang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an academic surgical pathologist. My goal is to improve human health through patient care of the highest quality, as well as performing laboratory research and educating physicians of the next generation
Education & Training
Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1999 - 2000
NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 1995 - 1999
CUNY School of MedicinePhD, Molecular and Cellular Biology, 1987 - 1991
Institute of Radiation MedicineMS, 1983 - 1986
Anhui Medical UniversityClass of 1983
Certifications & Licensure
CA State Medical License 2008 - 2028
NC State Medical License 2015 - 2027
NY State Medical License 1998 - 2010
American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Roberta Nieberg Faculty Teaching Award UCLA Pathology and Laboratory Medicine, 2008
- Eric A. Schenk Award for Excellence in Pathology Education University of Rochester Medical Center, 2006
- Scientific Exchange Award Leukemia Society of America, 1993
Publications & Presentations
PubMed
- Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.Furong Huang, Fuwen Yuan, Kexin Li, Ya Cui, Lei Li
Nature Biomedical Engineering. 2026-06-16 - Co-targeting EGFR and SUCLG2 disrupts a nuclear transcriptional program driving neuroendocrine differentiation and TKI resistance in castration-resistant prostate cancer.Wei-Yu Chen, Kuan-Hua Huang, Gagan Kajla, Yu-Ching Wen, Ming-Kun Liu
Cell Communication and Signaling. 2026-06-08 - Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neur...Rahul Aggarwal, Jingsong Zhang, Paul Monk, Xinhua Zhu, Rob Jones
Journal for Immunotherapy of Cancer. 2026-05-11
Journal Articles
- Reprogramming Normal Human Epithelial Tissues to a Common, Lethal Neuroendocrine Cancer LineageJiaoti Huang, John K Lee, Kim Nguyen, Science Magazine
- SRRM4 Gene Expression Correlates with Neuroendocrine Prostate CancerJiaoti Huang, MD, The Prostate
- Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision MakingAriel A Schulman, Jiaoti Huang, Thomas J Polascik, Jamie N Holtz, ScienceDirect
Press Mentions
MR Molecular Imaging of Extradomain-B Fibronectin for Assessing Progression and Therapy Resistance of Prostate CancerAugust 26th, 2024- Closing in on New Treatments for Prostate CancerFebruary 17th, 2023
- Tech Advances Are Enabling Faster, More Accurate Pathological Assessments of CancerApril 10th, 2022
Grant Support
- Targeting Undruggable Transcription Factor HoxB13 to Inhibit Prostate Cancer MetastasisDUKE UNIVERSITY2025–2029
- Targeting Undruggable Transcription Factor HoxB13 to Inhibit Prostate Cancer MetastasisDUKE UNIVERSITY2025–2029
- Targeting Undruggable Transcription Factor HoxB13 to Inhibit Prostate Cancer MetastasisDUKE UNIVERSITY2025–2029
- Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistanceDUKE UNIVERSITY2024–2029
- The role of focal adhesion kinase in therapy resistant prostate tumorsDUKE UNIVERSITY2023–2028
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
